Human Reproduction Update, Vol.9, No.2 pp.175-184, 2003
© European Society of Human Reproduction and Embryology 2003; all rights reserved
Pathophysiology of increased nuchal translucency: a review of the literature
1 Department of Obstetrics and Gynaecology, VU University Medical Center, Amsterdam, The Netherlands
To whom correspondence should be addressed at: Monique C. Haak, VU University Medical Center, Department of Obstetrics and Gynecology, L348, P.O. Box 7057, 1007 MB Amsterdam, the Netherlands. e-mail: mc.haak{at}vumc.nl
Abstract
First-trimester nuchal translucency (NT) measurement is a widely used technique to determine the risk of fetal aneuploidy. The aim of this review was to explore the different hypotheses on the aetiology of increased NT. Using a computerized database (PubMed), articles on the aetiology of first-trimester NT were retrieved. Furthermore, the cited references of the studied articles were used to find additional articles. Based on ultrasonographic and post-mortem morphological studies, the findings in increased NT fetuses are described and classified into three categories. First, an association between increased NT and cardiac abnormalities, combined with abnormal ductus venosus flow velocities, is found, leading to the theory that cardiac failure causes NT enlargement. Second, various types of abnormalities are found in the extracellular matrix of the nuchal skin of fetuses with increased NT. Third, abnormal lymphatic development is demonstrated in fetuses with increased NT. In conclusion, many hypotheses on NT enlargement are based on associations and speculations. This report provides an overview of the different theories and an attempt to fit the different associations and findings into a single hypothesis of abnormal embryological development.
Key words: animal models / first trimester / nuchal translucency / pathogenesis / trisomy 21
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. I.J. Wildschut, T.J. Peters, and C. P. Weiner Screening in women's health, with emphasis on fetal Down's syndrome, breast cancer and osteoporosis Hum. Reprod. Update, September 1, 2006; 12(5): 499 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Harry and K. L. Reed Nuchal Translucency and First-Trimester Screening Reproductive Sciences, April 1, 2006; 13(3): 153 - 154. [PDF] |
||||
![]() |
P.-J. Cheng, S.-D. Chang, S.-W. Shaw, and Y.-K. Soong Nuchal Translucency Thickness in Fetuses With Chromosomal Translocation at 11-12 Weeks of Gestation Obstet. Gynecol., May 1, 2005; 105(5): 1058 - 1062. [Abstract] [Full Text] [PDF] |
||||


